Business Context and Reporting Period
This Form 6-K filing by TNL Mediagene covers the month of September 2025, with a report date of September 16, 2025. The filing discloses a corporate action regarding an amendment to an existing equity line of credit agreement rather than a standard periodic financial report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the terms of a contractual amendment and does not contain financial performance data.
Material Changes
On September 14, 2025, TNL Mediagene and Tumim Stone Capital LLC entered into a third amendment to their Ordinary Share Purchase Agreement (dated November 25, 2024). The material change involves the valuation method for share purchases under the equity line of credit:
- TLN Mediagene may now select a pricing valuation period of either one (1) or three (3) trading days.
- Valuation is based on the market price and/or volume of the Ordinary Shares.
- Corresponding adjustments were made to the maximum purchase amount and purchase price.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, or an outlook for future periods. The document notes that the description of the amendment is qualified in its entirety by reference to the full text of the Amendment filed as Exhibit 99.1. No specific risks or contingencies are detailed in the summary text provided.
Investor Verification Checklist
- Review Exhibit 99.1 for the complete legal text of the Third Amendment to the Ordinary Share Purchase Agreement.
- Verify the specific formulas for the "one (1) trading day" versus "three (3) trading day" valuation periods.
- Confirm the adjusted maximum purchase amounts and price caps resulting from the amendment.
- Check subsequent filings for any actual share issuances or capital raised under the amended terms.